KINNATE BIOPHARMA INC - COM (KNTE)

CUSIP: 49705R105

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / COM
Total 13F shares
34,598,592
Share change
-3,802,213
Total reported value
$92,061,843
Put/Call ratio
847%
Price per share
$2.66
Number of holders
54
Value change
-$8,961,422
Number of buys
25
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 49705R105?
CUSIP 49705R105 identifies KNTE - KINNATE BIOPHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of KINNATE BIOPHARMA INC - COM (KNTE) as of Q1 2024

As of 31 Mar 2024, KINNATE BIOPHARMA INC - COM (KNTE) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,598,592 shares. The largest 10 holders included Foresite Capital Management IV, LLC, ORBIMED ADVISORS LLC, Foresite Capital Management V, LLC, Lynx1 Capital Management LP, VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, DELTEC ASSET MANAGEMENT LLC, TANG CAPITAL MANAGEMENT LLC, ACADIAN ASSET MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 54 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.